2 directorsName after signing inVisible after signing in and 1 other
Owners2 names in the annual accounts
50%Hidden nameVisible after signing in and 1 other
Documentsfilings and deeds
06-07-202625 days before the deadline
2025abbreviated format
Gross margin from €36,756 to €468,167Profit of €6,181, after a lossStaff from 1.3 FTE to 3.2 FTEEquity from €1,434 to €7,616Cash from €60,918 to €140,113
Lower solvency than 95% of companies in human health. The sector median is 59.4%, over 2,823 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 2,137 companies had the same profile as BIODENT has now. Each dot stands for 6 companies, two years later.
92.0%
were still trading
2.4%
stopped another way
5.2%
went bankrupt
Micro
2 to 5 years old
solvency under 10%
a profit under 5% of the balance sheet
Another 0.4% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,137 companies, not a prediction for BIODENT. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Hidden signalVisible after signing in
Signal visible after signing inVisible after signing in
Signal hidden, visible after signing inVisible after signing in
Board and ownership
Hidden nameVisible after signing in
Director, since 31-05-2023
Name after signing inVisible after signing in
Director, since 31-05-2023
Name hiddenVisible after signing in 50%score XXVisible after signing inequity €240,981 (2025) · annual accounts 30-09-2025 of Name after signing inVisible after signing in
Name hiddenVisible after signing in 50%score XXVisible after signing inequity €195,966 (2025) · annual accounts 30-09-2025 of Name after signing inVisible after signing in
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0802308675
Incorporation
Founding capital of €120,000, 1,200 shares · Founded by Name hiddenVisible after signing in and Hidden nameVisible after signing in · Name after signing inVisible after signing in (director) and Name hiddenVisible after signing in (director) appointed · published on 05-06-2023 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as BIODENT: dental practice (NACE 86230). They are comparable in size and age: total assets between €1.2m and €2.1m, founded between 2021 and 2024.
BIODENT has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €7,616 and a net result of €6,181.
Its solvency ranks better than 5% of 2,823 sector peers (NACE 86) in financial year 2025.
According to the KBO register, the main activity is dental practice (NACE 86230).
What is the legal form of BIODENT?
BIODENT is a private limited company (BV).
When was BIODENT founded?
BIODENT was founded on 01-06-2023.
Is BIODENT still active?
Yes, BIODENT is an active enterprise in the KBO register.
How many employees does BIODENT have?
BIODENT had an average of 3.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does BIODENT fall under?
In its 2025 annual accounts, BIODENT states joint committee 330 (Health institutions and services).
What is the turnover of BIODENT?
The turnover in financial year 2025 is about €900,000. This figure is estimated from the gross margin of €468,167 and 41 comparable companies (NACE 862). It probably lies between €610,000 and €1.4m.
Is BIODENT profitable?
In financial year 2025, BIODENT made a profit of €6,181.
Where can I find the annual accounts of BIODENT?
BIODENT filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of BIODENT due?
BIODENT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline